Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone

https://ift.tt/WhUJOou

from Sanofi - Aventis Groupe https://ift.tt/eKjVlJE
via IFTTT

" May good health envelop you, spurring a quick recovery. .. "

from health care https://ift.tt/teV6r3W
via IFTTT https://ift.tt/wGgCUsI

SHARE

Milan Tomic

Hi. I’m Designer of Blog Magic. I’m CEO/Founder of ThemeXpose. I’m Creative Art Director, Web Designer, UI/UX Designer, Interaction Designer, Industrial Designer, Web Developer, Business Enthusiast, StartUp Enthusiast, Speaker, Writer and Photographer. Inspired to make things looks better.

• 
• 
• 
• 
•